Endo International plc is an American Irish-domiciled generics and specialty branded pharmaceutical company that generated over 93% of its 2017 sales from the U.S. healthcare system. From Wikipedia
The merger will create a new pharmaceutical entity with a global footprint, expected to list on the NYSE and generate significant cost synergies.
